Acorda settlement effect! Aurobindo Pharma ascends over 1%
US-based Acorda Therapeutics, Inc has entered into a settlement agreement with Aurobindo Pharma Ltd to resolve pending patent litigation brought by the company against Aurobindo involving Ampyra (dalfampridine) Extended-Release Tablets,